Beijing, China

Chunxia Zhou

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Chinese Academy of Medical Sciences. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chunxia Zhou. Retrieved from https://idiyas.com/inventor/chunxia-zhou-6j4mu2vw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Chunxia Zhou in Vaccine Development

Introduction

Chunxia Zhou is a prominent inventor based in Beijing, China. She has made significant contributions to the field of vaccine development, particularly through her innovative research and patents. Her work focuses on recombinant gene sequences that have the potential to enhance vaccine efficacy.

Latest Patents

Chunxia Zhou holds 1 patent for her invention titled "Recombinant chemokine-antigen vaccine." This patent describes a recombinant gene sequence that comprises the human SLC gene, an antigen gene, and an IgG1-Fc fragment gene. The SLC gene is linked upstream to the antigen gene, while the IgG1-Fc fragment is linked downstream to the antigen gene. This invention also relates to the application of the recombinant gene sequence in the preparation of gene vaccines.

Career Highlights

Chunxia Zhou is affiliated with the Chinese Academy of Medical Sciences, where she conducts her research and development activities. Her work has garnered attention for its potential impact on vaccine technology and public health.

Collaborations

Chunxia Zhou collaborates with notable colleagues, including Wenbo Ma and Chen Lin. These partnerships enhance her research efforts and contribute to the advancement of innovative solutions in the medical field.

Conclusion

Chunxia Zhou's contributions to vaccine development through her innovative patent demonstrate her commitment to advancing medical science. Her work has the potential to significantly impact public health and vaccine efficacy in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…